federal drug policy

DEA Emergency Scheduling of Mitragynine-Pseudoindoxyl Could Ban Kratom Containing Trace Amounts of the Molecule

Notice #DEA-1571 (Federal Register Docket #2026-13581) intends to ban mitragynine pseudoindoxyl with no legal threshold that allows for naturally occurring trace amounts in drying kratom leaves. AKA asks comedian Joe Rogan for help. Two Notices of Intent related to kratom alkaloids were filed by the Drug Enforcement Administration (DEA) on July 1, 2026. One, titled …

DEA Emergency Scheduling of Mitragynine-Pseudoindoxyl Could Ban Kratom Containing Trace Amounts of the Molecule Read More »

Last Day to Comment on 7-OH Schedule I Placement; Hamilton Morris, Carl Hart Speak Out in Opposition

Tonight at 11:59 PM, the Department of Health and Human Services (HHS) will close comments on the notice “Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I; Request for Information“. The notice asks for specific information and scientific evidence about the threshold of 7-OH that should be allowable in kratom products. However, many …

Last Day to Comment on 7-OH Schedule I Placement; Hamilton Morris, Carl Hart Speak Out in Opposition Read More »

Trump Says His Administration is Looking to Approve “Natural 7-OH”

Following a White House meeting on drug policy on Monday, May 11, 2026, President Donald Trump told a small group of reporters, “We’re looking very seriously at natural 7‑OH and getting that approved.” In 2025, Food and Drug Administration (FDA) Commissioner Marty Makary and Health and Human Services (HHS) Secretary Robert Kennedy gave a press …

Trump Says His Administration is Looking to Approve “Natural 7-OH” Read More »